.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
QuintilesIMS
UBS
Moodys
Cipla
Merck
Fish and Richardson
Johnson and Johnson
Teva
Cantor Fitzgerald

Generated: December 12, 2017

DrugPatentWatch Database Preview

Ibuprofen - Generic Drug Details

« Back to Dashboard

What are the generic sources for ibuprofen and what is the scope of ibuprofen patent protection?

Ibuprofen
is the generic ingredient in forty-four branded drugs marketed by Pfizer, Amneal Pharms, Bionpharma Inc, Contract Pharmacal, Humanwell Puracap, Marksans Pharma, P And L Dev Llc, Sofgen Pharms, Bayer, Cumberland Pharms, J And J Consumer Inc, L Perrigo Co, Tris Pharma Inc, Mcneil, Wyeth Cons, Moberg Pharma North, Perrigo, Abbott, Actavis Mid Atlantic, Arise Pharms, Hi-tech Pharmacal, Perrigo R And D, Taro, Mcneil Consumer, Mcneil Ped, Lederle, Basf, Alra, Pliva, Aiping Pharm Inc, Amneal Pharms Ny, Ani Pharms Inc, Aurobindo Pharma Ltd, Aurolife Pharma Llc, Avema Pharma, Dr Reddys La, Dr Reddys Labs Inc, Granules India, Granules India Ltd, Halsey, Ivax Sub Teva Pharms, Leiner, LNK, Merro Pharm, Mylan, Mylan Pharms Inc, Northstar Hlthcare, OHM, Ohm Labs, Par Pharm, Purepac Pharm, Sandoz, Strides Pharma, Sun Pharm Industries, Superpharm, Teva, Vintage Pharms, Watson Labs, Bristol Myers, Exela Pharma Science, Recordati Rare, Pfizer Cons Hlthcare, Forest Labs, Actavis Elizabeth, Barr Labs Inc, and Dr Reddys Labs Ltd, and is included in two hundred and four NDAs. There are thirteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ibuprofen has forty patent family members in eleven countries.

There are sixty-four drug master file entries for ibuprofen. Two hundred and sixty-three suppliers are listed for this compound.

Pharmacology for ibuprofen

Medical Subject Heading (MeSH) Categories for ibuprofen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms IncIBUPROFENibuprofenTABLET;ORAL070045-001Sep 24, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mcneil PedMOTRINibuprofenTABLET, CHEWABLE;ORAL020135-002Nov 16, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Contract PharmacalIBUPROFENibuprofenTABLET;ORAL071268-003Jul 1, 1988ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mcneil ConsumerMOTRINibuprofenTABLET;ORAL017463-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Par PharmIBUPROFENibuprofenTABLET;ORAL070329-001Aug 6, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MylanIBUPROFENibuprofenTABLET;ORAL070057-001Sep 24, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Humanwell PuracapIBUPROFENibuprofenCAPSULE;ORAL206568-001Jun 21, 2016OTCNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Granules India LtdIBUPROFENibuprofenTABLET;ORAL091625-001Sep 15, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LederleIBUPROFENibuprofenTABLET;ORAL070630-001Sep 19, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
OhmIBUPROFENibuprofenTABLET;ORAL071163-001Jul 15, 1986OTCNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ibuprofen

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
J And J Consumer IncJUNIOR STRENGTH MOTRINibuprofenTABLET, CHEWABLE;ORAL020601-003Nov 15, 1996► Subscribe► Subscribe
J And J Consumer IncCHILDREN'S MOTRINibuprofenSUSPENSION/DROPS;ORAL020603-001Jun 10, 1996► Subscribe► Subscribe
Mcneil PedMOTRINibuprofenTABLET, CHEWABLE;ORAL020135-001Nov 16, 1994► Subscribe► Subscribe
Mcneil PedMOTRINibuprofenTABLET, CHEWABLE;ORAL020135-001Nov 16, 1994► Subscribe► Subscribe
J And J Consumer IncCHILDREN'S MOTRINibuprofenTABLET, CHEWABLE;ORAL020601-001Nov 15, 1996► Subscribe► Subscribe
J And J Consumer IncCHILDREN'S MOTRINibuprofenSUSPENSION;ORAL020516-001Jun 16, 1995► Subscribe► Subscribe
Mcneil PedMOTRINibuprofenTABLET, CHEWABLE;ORAL020135-002Nov 16, 1994► Subscribe► Subscribe
Mcneil ConsumerMOTRINibuprofenSUSPENSION;ORAL019842-001Sep 19, 1989► Subscribe► Subscribe
Mcneil PedMOTRINibuprofenTABLET, CHEWABLE;ORAL020135-002Nov 16, 1994► Subscribe► Subscribe
Wyeth ConsCHILDREN'S ADVILibuprofenSUSPENSION;ORAL019833-002Sep 19, 1989► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: ibuprofen

Country Document Number Estimated Expiration
Germany60034044► Subscribe
China102791268► Subscribe
World Intellectual Property Organization (WIPO)2010105129► Subscribe
South Korea20120089623► Subscribe
Australia7094900► Subscribe
European Patent Office2515906► Subscribe
Australia780212► Subscribe
Japan5837877► Subscribe
European Patent Office2405748► Subscribe
World Intellectual Property Organization (WIPO)2005065674► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Covington
Cipla
Novartis
Moodys
Colorcon
Argus Health
Medtronic
Queensland Health
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot